92 related articles for article (PubMed ID: 21078287)
1. Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion.
Miyazaki T; Miyauchi S; Anada T; Imaizumi H; Suzuki O
Anal Biochem; 2011 Mar; 410(1):7-12. PubMed ID: 21078287
[TBL] [Abstract][Full Text] [Related]
2. Effect of chondroitin sulfate-E on the osteoclastic differentiation of RAW264 cells.
Miyazaki T; Miyauchi S; Tawada A; Anada T; Suzuki O
Dent Mater J; 2010 Aug; 29(4):403-10. PubMed ID: 20610874
[TBL] [Abstract][Full Text] [Related]
3. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
Sugawara K; Hamada M; Hosoi S; Tamaoki T
Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
[TBL] [Abstract][Full Text] [Related]
4. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
5. Volumetric analysis of osteoclastic bioresorption of calcium phosphate ceramics with different solubilities.
Winkler T; Hoenig E; Gildenhaar R; Berger G; Fritsch D; Janssen R; Morlock MM; Schilling AF
Acta Biomater; 2010 Oct; 6(10):4127-35. PubMed ID: 20451677
[TBL] [Abstract][Full Text] [Related]
6. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
7. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro.
Faucheux C; Verron E; Soueidan A; Josse S; Arshad MD; Janvier P; Pilet P; Bouler JM; Bujoli B; Guicheux J
J Biomed Mater Res A; 2009 Apr; 89(1):46-56. PubMed ID: 18404716
[TBL] [Abstract][Full Text] [Related]
9. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
[TBL] [Abstract][Full Text] [Related]
10. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of (-)-saucerneol on osteoclast differentiation and bone pit formation.
Kim SN; Kim MH; Kim YS; Ryu SY; Min YK; Kim SH
Phytother Res; 2009 Feb; 23(2):185-91. PubMed ID: 18690659
[TBL] [Abstract][Full Text] [Related]
13. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
[TBL] [Abstract][Full Text] [Related]
14. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity.
Ren W; Li XH; Chen BD; Wooley PH
J Orthop Res; 2004 Jan; 22(1):21-9. PubMed ID: 14656655
[TBL] [Abstract][Full Text] [Related]
15. Chondroitin Sulfate-E Binds to Both Osteoactivin and Integrin αVβ3 and Inhibits Osteoclast Differentiation.
Miyazaki T; Miyauchi S; Anada T; Tawada A; Suzuki O
J Cell Biochem; 2015 Oct; 116(10):2247-57. PubMed ID: 25820496
[TBL] [Abstract][Full Text] [Related]
16. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
17. S 12911-2 inhibits osteoclastic bone resorption in vitro.
Takahashi N; Sasaki T; Tsouderos Y; Suda T
J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin F(2alpha) negatively regulates bone resorption in murine osteoclast development.
Kamon M; Fujita D; Goto N; Amano H; Sakamoto K
Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):26-33. PubMed ID: 18638564
[TBL] [Abstract][Full Text] [Related]
19. Characterization of biomimetic calcium phosphate labeled with fluorescent dextran for quantification of osteoclastic activity.
Maria SM; Prukner C; Sheikh Z; Müller FA; Komarova SV; Barralet JE
Acta Biomater; 2015 Jul; 20():140-146. PubMed ID: 25829107
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
